The tumor microenvironment (TME) provides a protective niche supporting CLL cell survival and proliferation through activation of key pathways including B-cell receptor (BCR) and Toll-like receptor (TLR) signaling (2, 3). The gene discussed is BCR; the disease is B-cell chronic lymphocytic leukemia.